Maxalt (Rizatriptan Benzoate)

Rizatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This action causes vasoconstriction of dilated intracranial arteries and blocks the release of inflammatory neuropeptides, thereby aborting a migraine attack.

The appropriate dose of Maxalt is determined by a qualified prescriber based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the dosing instructions provided by their healthcare professional.

Safety data for rizatriptan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by the prescribing clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maxalt belongs to the triptan class, which is generally more effective for moderate to severe migraine attacks than simple analgesics. Compared with other triptans, rizatriptan has a rapid onset of action and a relatively short half‑life, making it suitable for patients who need quick relief.

Store Maxalt tablets at ambient temperature, preferably below 25 °C, in the original container to protect from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged.

Maxalt is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, preferably at the first sign of a migraine attack. Patients should not crush, chew, or dissolve the tablet.

Serious risks include coronary vasospasm, which can cause chest pain or heart attack, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience severe chest discomfort, rapid heartbeat, or signs of an allergic reaction.

Maxalt should be avoided in patients with uncontrolled cardiovascular disease, a history of myocardial infarction, severe hepatic impairment, or known hypersensitivity to rizatriptan or any tablet excipients. It is also contraindicated in combination with ergot derivatives or other triptans.